Home
Fairmount Healthcare Fund II, Director: Spyre Therapeutics SYRE Sell · Filed 06/23
Trade details
- Type
- Insider sale
- Amount
- $399,658,667.11
- Shares · price
- 4,684,781 sh · $85.31 a share
- Held after
- 0 sh
- Trade date
- 26/06/23
- Filed
- 26/06/23
- Days to filing
- 0 days
Sold 100.0% of holdings
- Share of holding sold
- 100.0%
Spyre Therapeutics trades, last 26 weeks
What else happened in Spyre Therapeutics around then
Filed or reported within 30 days of the trade day · 05/24~07/23Fairmount Healthcare Fund II's recent trades
- Fairmount Healthcare Fund II
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$20M
1,176,470 sh
$20M
Filed 05/13
Traded 05/11
- Fairmount Healthcare Fund II
BuyZenas BioPharma
BuyZenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
- Fairmount Healthcare Fund II
SellApogee Therapeutics
SellApogee Therapeutics
APGE
$133.5M
1,750,000 sh
$133.5M
Filed 01/22
Traded 01/22
- Fairmount Healthcare Fund II
BuyCrescent Biopharma
BuyCrescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
- Fairmount Healthcare Fund II
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$10M
454,545 sh
$10M
Filed 25/10/27
Traded 25/10/23
